Supernus Pharmaceuticals, Inc. (SUPN)

Supernus Pharmaceuticals Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for SUPN stock has a target of 41, which predicts an increase of 35.54% from the current stock price of 30.25.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$41	$41	$41	$41
Change	+35.54%	+35.54%	+35.54%	+35.54%

* Price targets were last updated on Feb 28, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for SUPN is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '24	Mar '24	Apr '24	May '24	Jun '24	Jul '24
Strong Buy	0	0	0	0	0	0
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Amsellem Piper Sandler	Piper Sandler	Buy Maintains $45 → $41	Buy	Maintains	$45 → $41	+35.54%	Feb 28, 2024
David Amsellem Piper Sandler	Piper Sandler	Buy Maintains $42 → $43	Buy	Maintains	$42 → $43	+42.15%	Nov 9, 2023
David Amsellem Piper Sandler	Piper Sandler	Buy Maintains $43 → $42	Buy	Maintains	$43 → $42	+38.84%	Oct 25, 2023
David Amsellem Piper Sandler	Piper Sandler	Buy Maintains $45 → $46	Buy	Maintains	$45 → $46	+52.07%	May 10, 2023
David Amsellem Piper Sandler	Piper Sandler	Buy Maintains $40 → $47	Buy	Maintains	$40 → $47	+55.37%	Jan 23, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

612.12M

Increased by 0.76%

from 607.52M

Revenue Next Year

637.10M

Increased by 4.08%

from 612.12M

EPS This Year

1.78

Increased by 8,808.02%

from 0.02

EPS Next Year

2.14

Increased by 20.04%

from 1.78

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	392.76M	520.40M	579.78M	667.24M	607.52M	612.12M	637.10M	707.33M	794.87M	852.41M
Revenue Growth	-3.95%	32.50%	11.41%	15.09%	-8.95%	0.76%	4.08%	11.02%	12.38%	7.24%
EPS	2.10	2.36	0.98	1.04	0.02	1.78	2.14	2.87	4.07	4.90
EPS Growth	2.44%	12.38%	-58.47%	6.12%	-98.08%	8,808.02%	20.04%	34.18%	41.82%	20.30%
Forward PE	-	-	-	-	-	16.98	14.14	10.54	7.43	6.18
No. Analysts	-	-	-	-	-	6	6	6	4	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	640.6M	695.9M	777.7M	841.8M	894.0M
Avg	612.1M	637.1M	707.3M	794.9M	852.4M
Low	576.7M	581.4M	639.2M	750.8M	803.6M

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	5.4%	13.7%	22.1%	19.0%	12.5%
Avg	0.8%	4.1%	11.0%	12.4%	7.2%
Low	-5.1%	-5.0%	0.3%	6.2%	1.1%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	1.94	2.60	3.52	4.25	5.04
Avg	1.78	2.14	2.87	4.07	4.90
Low	1.63	1.53	1.90	3.85	4.70

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	9,612.5%	46.2%	64.5%	48.2%	23.8%
Avg	8,808.0%	20.0%	34.2%	41.8%	20.3%
Low	8,034.0%	-14.2%	-11.1%	34.2%	15.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.